The role of PIEZO1 in MS can be summarized into three main aspects: demyelination and axonal degeneration, activation of macrophage and oligodendrocyte inflammation, and involvement in T cell receptor (TCR) activation (Radandish et al., 2021). Here, PIEZO1 is linked to myeloid sarcoma.